Biovail Takes Over Valeant via Reverse Merger to Expand Business Model
By Heather Cartwright
Pharma Deals Review: Vol 2010 Issue 7 (Table of Contents)
Published: 8 Sep-2010
DOI: 10.3833/pdr.v2010.i7.1366 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
Biovail, Canada’s largest publicly owned pharmaceutical company, is to take over US-based Valeant Pharmaceuticals International in a transformational deal, valued at approximately US$3...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS